Real world outcomes in patients with acquired thrombotic thrombocytopenic purpura (TTP) treated with caplacizumab
Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417019081
Cites:
Cited by:
Related to:
